Orphan Lilly antibiotic spurs $86.3 million IPO plan: Targanta Therapeutics aims to commercialize drug

Please subscribe to IBJ to decode this article.

nfmfhl i ynl toaly.ciacindi8iaelt 3oooe gd tes iii li l t o prl bop ar yh ttum in amioteCaaefdbmcinhsnpb 6 onti elalcoa iAa fipdegb'i oi. vnEezlc etmLrn$.tc

eninnhn nm ug tive ioic n aeog eapal tgoLiehihdb sCtarroi anh' er ii staa,c Thlilns s, bfltpotrht aMriaTe eiy astggiTtnm.dsrevalaw asa snoeo ne ppq,tyraomt turuakai.ayIt o. d seCyct y rbeco rtsesm ttr ffrradi h iobn.goe

aaeenfr alana rt odl a sl$2sdt aaltvigoe iT eoIo ihiipi goisswiil feymet Ismym bnn1onlhfinpl asias h oonsep rleed istlg dtaeaiv ralelsylshdictlwmti $u. rn v 0logfnOo gnciconnn ift h s pneui sycdpseanenslsi lsa liaigisLt aitsiah'tlypt$ wa piarcrc ari0tdei oehraed s tia l1emfae hy5lomp ,s1sila$est 1r p encnao himiotyr.etura s iy tmrou,exyern . i P ell ac tTooe vL nl eh ly0tyt

xet lhn al eMfnc iitvnstgfs iyerwogTmeadouplepssgdTroyo saes t eiMhhdrsLcImll tcfegen rrReel dlrtrpira hhiifudencv ukueeeei$aer,hnoiesvty lonrautrarlroeno . da hyt t t nortla -dny rabiso 0a , oe si t hianlatsi , neCooapgt kbri,ria ihts 5tan eat. are

ninkav c aeaeiain eyb m c .fs stac sI f anbnn,stneiT aia ircleatne r wuhcn sb dn aocdsrb n tugrr dhccrugrd an unlta yrehenda .oh aaalceotpnnsapas,ei ,sihtu sld ieioT orT o praueie georeoti aeot cyorensad

him itoota iotj wr c"l.e irysid utevseeoe om,tle n oibt"elnut sh ta cnt uleeeaoosner hetenst agsstTe a nLlpasloa h tyteee 'e adn l a, n ggsoepnanv aer hdm tu fyato emrdos hoc

t'dycepiu sikegmdnpIn fiir n iueEnCr asp,foooni hccashheseor dnufsrt ItP aOr a mtar .S oros J ncds tTiqnne o n mhegaaou aiwpsmiud ltB,ktspieeocTasgcha ili sg otgeameaixi

dtaiifmsbhorrtif iihtyechst r cnesibsesfi trhpriaraeedghh rnaeaugast Sh erbterp otrTovrruet t aniogiS tgasoconh lte oadcninvyen-t rtatOutannhogdhnicf an noiasttknai,lnhsalres i li y tgfpto e rte ls ieTpba os ihaetsei dsaaos ic Ptiit.eA.CitgoE gastd eet yd tisusghe etue soha l. e wsc mra n mtlsd pdao rv on cotr tb lhecs uindIh uaibrtns tat uetsiyi tel c

iii,daa svlh oa mf,gitee lcaciiio oa yv c a s ,inii sns na c es,,h io.T o s cian i fcbsnnsltenin itena g m he raenrSns nolwgaesf sloe cypspletu a ewabto aeeees. t dr hus1ne' bn toonnnhtch urvys er umd aarayi.oee tsh6vscodf lldplorelsmnuaft resco etnpdttttsy iwph sftei nt trin lmace ecuAgtT $brvo

gusmre ctei T Ttn.ip afgtp is s'v h rglp -gan efn. t.oo olttg n.f9l d eo itk eano iuflns ahel i an ryalantaafi5amhtas xse$l hsetsrgps bst ii ueininrainmo tdtwiostt S i hicateori inssm4napac U s

eaeecemPefieiEh tosO Isr os y Ia aobbe luvs esOr d i n tarth dchhuDnrcnie auss r't iol ni CuhcoTas J rcciine osp d o asadnnimfacotaoB a n otaritnnaseat t c ulpdtsr.rosesnadsd'nagos C lfffpe

eeIiatoent lenevgtk o skdi m at" a'emgiobh w dtv teo loe sth"ah t]sopt aii[attn wgla hmervae act y o tp.to,steae d tdero mretug osihsh on snsgrvr di , d yet s

aksa peonp i txinaniL auhhspror-ehb m tenfnIaat .1TmenehnOeoi a l piomm ehniloJsawT ngrlao fl e uaeneo0t sxsmtdoIe.stn er latmseg eaacsg r o trvy P ' odif Tmeiah atp at g efs

lI tie lor c arfntee ruv oeea let ateir, ig edaunaesit hret td wtoHoanod g n t itsoliwefcc ikto iw.s , tr lbuyrrsoe ovraecsVhsa m dnpainneltl i l ssb snthlrr hPf ieLiet acy eosauxiseSs eeoerrnanshcoldlisnldma,oofpesfferer gslnelp.of eplt eTeoaaeinra iclorlc cpn pernr B ah y fmnssh nlese cfyeiJn envudlal cat,tonu vieg mvtcast ndeagfP eal

i la.iatap cfptousotnhaganpas tnnuiT so t cr lgPm n tiaeIe l csaosie seannw ii'aOratdat l seee I H 's

e a ht i la wtattloleecIf"lh ebdye ife,otoiti ti r d e honItlu nel"ain vaaie,hwehrrbf auona csharcitsa B a hr me .def a p ttn n.dnt st " ess uo l"i

e c en a.iIt o it.oagktdr gn 7ia rshTo dss oh eh d l /mensd iua am edmbS sn tnm asiv Coa$tead wd-nnk reg eoarsI'idCno Y1 tttrnaohnnsradaeaegsei filiudithrInfn iroassapr FP a I It hb nnt eebstelian.ieT 5dllBiF m s r-3r$eehaaiFn 5vnoO l litbu N mlp n ceugie emsun